本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viking Therapeutics, Inc.

34.17
+0.94002.83%
盤後34.170.00000.00%19:53 EDT
成交量:209.60萬
成交額:7,189.06萬
市值:39.86億
市盈率:-7.32
高:34.99
開:33.67
低:33.43
收:33.23
52周最高:43.15
52周最低:22.96
股本:1.17億
流通股本:1.10億
量比:1.19
換手率:1.91%
股息:- -
股息率:- -
每股收益(TTM):-4.6676
每股收益(LYR):-3.1920
淨資產收益率:-88.85%
總資產收益率:-51.86%
市淨率:9.76
市盈率(LYR):-10.70

資料載入中...

2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/25

重要事件披露

Form 8-K - Current report
2023/07/27

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/26

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report